Pharmaceutical Contract Development & Manufacturing Market
Dublin, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development & Manufacturing Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Pharmaceutical Contract Development & Manufacturing Market is projected to reach USD 176.91 billion by 2027 from USD 107.61 billion in 2021, at a CAGR 8.63% during the forecast period.
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.
In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
The Americas Pharmaceutical Contract Development & Manufacturing Market size was estimated at USD 37,848.04 million in 2021, is expected to reach USD 40,998.19 million in 2022, and is projected to grow at a CAGR of 8.59% to reach USD 62,062.90 million by 2027.
The Asia-Pacific Pharmaceutical Contract Development & Manufacturing Market size was estimated at USD 32,241.32 million in 2021, is expected to reach USD 35,132.97 million in 2022, and is projected to grow at a CAGR of 8.80% to reach USD 53,490.17 million by 2027.
The Europe, Middle East & Africa Pharmaceutical Contract Development & Manufacturing Market size was estimated at USD 37,525.20 million in 2021, is expected to reach USD 40,589.67 million in 2022, and is projected to grow at a CAGR of 8.54% to reach USD 61,358.02 million by 2027.
Market Segmentation & Coverage:
The report on pharmaceutical contract development & manufacturing identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making.
This market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.
This research report categorizes the pharmaceutical contract development & manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
Biologics Manufacturing Services
Biologics API Manufacturing Services
Biologics FDF Manufacturing Services
Drug Development Services
Pharmaceutical Manufacturing Services
Pharmaceutical API Manufacturing
Capsule Manufacturing Services
Oral Liquid Manufacturing Services
Parenteral/Injectable Manufacturing Services
Tablet Manufacturing Services
Pharmaceutical FDF Manufacturing
Secondary Packaging Services
Generic Pharmaceutical Companies
Small & Mid-Size Pharma
Europe, Middle East & Africa
United Arab Emirates
Company Usability Profiles:
Aenova Group GmbH
C.H. Boehringer Sohn AG & Ko. KG
Delwis Healthcare Pvt Ltd.
Evonik Industries AG
Famar Health Care Services
Jubilant Life Sciences Limited
Lonza Group AG
Serum Institute of India Ltd.
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Vetter Pharma-Fertigung GmbH & Co. KG
For more information about this report visit https://www.researchandmarkets.com/r/ygj1w
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900